With Phase 1 testing now complete and showing positive results, U.S.
Specialty Formulations of Allentown is moving forward with the oral COVID-19 vaccine that it is producing.
This entry was posted on Wednesday, July 20th, 2022 at 7:11 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.
Comments are closed.